Poolbeg Pharma Ltd. (7JN) Financial Statements
Poolbeg Pharma Ltd. Financial Overview
Poolbeg Pharma Ltd.'s market cap is currently $59.33M. The company's EPS TTM is $-0.01; its P/E ratio is -8.33; Poolbeg Pharma Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -59.00K | $ -114.00K | $ -26.00K | $ -26.00K | $ -18.00K |
| Operating Income | $ -6.42M | $ -6.62M | $ -5.04M | $ -4.99M | $ -2.38M |
| EBITDA | $ -6.36M | $ -6.00M | $ -4.66M | $ -4.75M | $ -2.32M |
| Net Income | $ -5.70M | $ -5.79M | $ -3.93M | $ -4.69M | $ -2.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.71M | $ 7.82M | $ 12.17M | $ 16.19M | $ 20.95M |
| Total Assets | $ 9.94M | $ 10.25M | $ 15.43M | $ 19.29M | $ 23.02M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -7.71M | $ -7.82M | $ -12.17M | $ -16.19M | $ -20.95M |
| Total Liabilities | $ 1.34M | $ 974.00K | $ 986.00K | $ 966.00K | $ 438.00K |
| Stockholders' Equity | $ 8.60M | $ 9.27M | $ 14.44M | $ 18.32M | $ 22.58M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.84M | $ -4.78M | $ -4.02M | $ -4.96M | $ -2.23M |
| Operating Cash Flow | $ -4.51M | $ -4.65M | $ -4.38M | $ -4.37M | $ -2.15M |
| Investing Cash Flow | $ -80.00K | $ 299.00K | $ 359.00K | $ -388.00K | $ -81.00K |
| Financing Cash Flow | $ 4.48M | $ 0.00 | $ 0.00 | $ 0.00 | $ 23.18M |
Currency in GBP